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Abstract
We explored the impact of Nox-2 in modulating inflammatory-mediated microglial responses in the 6-
hydroxydopamine (6-OHDA)-induced Parkinson’s disease (PD) model. Nox1 and Nox2 gene expression were found
to increase in striatum, whereas a marked increase of Nox2 expression was observed in substantia nigra (SN) of
wild-type (wt) mice after PD induction. Gp91phox-/- 6-OHDA-lesioned mice exhibited a significant reduction in the
apomorphine-induced rotational behavior, when compared to wt mice. Immunolabeling assays indicated that striatal
6-OHDA injections reduced the number of dopaminergic (DA) neurons in the SN of wt mice. In gp91phox-/- 6-OHDA-
lesioned mice the DA degeneration was negligible, suggesting an involvement of Nox in 6-OHDA-mediated SN
degeneration. Gp91phox-/- 6-OHDA-lesioned mice treated with minocycline, a tetracycline derivative that exerts multiple
anti-inflammatory effects, including microglial inhibition, exhibited increased apomorphine-induced rotational behavior
and degeneration of DA neurons after 6-OHDA injections. The same treatment also increased TNF-α release and
potentiated NF-κB activation in the SN of gp91phox-/--lesioned mice. Our results demonstrate for the first time that
inhibition of microglial cells increases the susceptibility of gp91phox-/- 6-OHDA lesioned mice to develop PD. Blockade
of microglia leads to NF-κB activation and TNF-α release into the SN of gp91phox-/- 6-OHDA lesioned mice, a likely
mechanism whereby gp91phox-/- 6-OHDA lesioned mice may be more susceptible to develop PD after microglial cell
inhibition. Nox2 adds an essential level of regulation to signaling pathways underlying the inflammatory response
after PD induction.
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Introduction
NADPH oxidases (Noxes) are multi-subunit enzymes able to
transfer electrons across biological membranes, catalyzing the
reduction of oxygen to O2·− (superoxide) at the expense of
NADPH. Superoxide is the primary product of the electron
transfer, but other downstream reactive oxygen species (ROS),
such as hydrogen peroxide (H2O2), can also be generated [1,2].
Considering the high susceptibility of the nervous tissue to
oxidative damage, the expression of a specialized enzymatic
system able to produce ROS in the brain not as a byproduct,
but rather as the primary function of the enzymatic complex,
was considered unlikely for a long time [3]. However, Nox
family members and the ROS they generate have been
identified as important contributors to the regulation of
physiological and pathological events in the nervous system
[3-5]. Seven Nox isoforms have been identified so far: Nox1,
gp91phox (Nox2), Nox3, Nox4, Nox5, and Dual Oxidases 1 and 2
(Duox1 and Duox2). Expression of each of them varies
according to different tissues and species. In the central
nervous system, the presence of Nox1, Nox2, Nox3, and Nox4
isoforms has been identified in several brain structures [6]. The
misregulation of Nox isoforms has been linked to a variety of
neurodegenerative conditions such as Alzheimer’s and
Parkinson’s diseases (PD) [7-10] and, as a consequence,
these enzymes have been proposed as a potential
pharmacological target for slowing disease progression [11].
However, the mechanisms involved are complex and still
incompletely understood. In relation to Parkinson’s disease
(PD), a neurodegenerative disorder characterized by the
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progressive loss of dopaminergic (DA) neurons of the
nigrostriatal pathway of the brain, increasing evidence has
suggested the involvement of oxidative stress caused by
overactivation of this enzymatic system on its pathogenesis
[12,13]. Recently, Nox1expression was found to be increased
in the substantia nigra (SN) of PD patients, suggesting that the
Nox complex plays a role in the degeneration of those neurons.
In addition, the genetic intervention on Nox1 and its chemical
inhibition protected nuclear DNA from oxidative stress damage
[14]. In rat primary mesencephalic cultures a significantly
increased ROS production and Nox subunit protein expression
were observed and as early as 24 h after administration of 6-
hydroxydopamine (6-OHDA), a classical toxin-inducing PD
model. Furthermore, the Nox subunities gp91phox and p47phox
were intensely expressed in microglial cells [15,16]. In line with
these findings, degeneration of DA neurons induced by 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was
attenuated in gp91phox-/- mice in comparison to the Wt mice [17].
In the present study, we explored the impact of Nox-2 in
modulating inflammatory-mediated microglial responses in the
6-OHDA-induced PD model. Hereby we present critical
evidence that inhibition of microglial cells with minocycline in
gp91phox-/- mice increases the susceptibility of these mice to
develop PD through nuclear factor kappa B (NF-κB) activation
and tumor necrosis factor alpha (TNF-α) release into SN.
Materials and Methods
Animals
Ten week-old male gp91phox-/- mice (Jackson Laboratories,
Maine, USA) (n = 60), along with wild type (Wt) mice (C57BL/6)
(n = 70) were used throughout this study. The animals had free
access to food and water and were maintained on a 12: 12 h
light–dark cycle. Experiments were performed with age- and
weight-matched (25-30g) animals. All procedures were
approved by the Institutional Animal Care Committee of the
Institute of Biomedical Sciences, University of São Paulo.
Surgical procedures
In order to lesion the nigrostriatal system, 6-OHDA was
unilaterally injected into the right striatum of both gp91phox-/- and
Wt mice. The animals were anaesthetized using 2-2-2
tribromoethanol (2%, Sigma-Aldrich Co., St. Louis, MO, USA)
and placed into a stereotaxic frame with nose and ear bars
specially adapted for mice. 6-OHDA (Sigma Chemical Co., St.
Louis, MO, USA) was dissolved at a concentration of 10 µg/µl
in saline (NaCl 0.9%) with 0.1% ascorbic acid [18]. The
injection was performed using a Hamilton syringe (model 701)
at the following coordinates: AP: −0.4 mm; ML: ±2.0 mm; DV:
3.0 mm relative to the bregma [19]. The total volume injected
was 1 µl. The injection was conducted at a rate of 0.5 µl/min
and the needle was left in place for additional 3 min before it
was slowly removed. The left striatum received 1µl of vehicle
(saline in 0.1% ascorbic acid) in the same coordinates and was
used as a control. Additionally, sham-operated mice were
infused with 1 µl of vehicle into both right and left striatum and
served as controls in the apomorphine-induced rotation test.
Clinical signs were also monitored daily after the surgery,
including general body condition and dehydration. Behavioral
analyses were typically conducted during the morning hours.
The animals were euthanized for analysis 15 days after the
surgery.
RNA isolation, cDNA synthesis and real-time PCR
Tissue from the SN and striatum from Wt mice were directly
homogenized in 1 ml TRIzol (Invitrogen, Carlsbad, CA, USA)
and total RNA was isolated following the manufacturer’s
suggested protocol. Following two chloroform extraction steps,
RNA was precipitated with isopropanol and the pellet washed
twice in 70% ethanol. After air-drying, RNA was resuspended
in DEPC-treated water and the concentration of each sample
obtained from A260 measurements. Residual DNA was removed
using DNase I (Amersham, Piscataway, NJ, USA) by following
the manufacturer’s protocol. For each 20 µl reverse
transcription reaction, 2 µg total RNA was mixed with 1 µl
oligodT primer (0.5 µg; Invitrogen) and incubated for 10 min at
65 °C. After cooling on ice the solution was mixed with 4 µl 5×
first strand buffer, 2 µl of 0.1 M DTT, 1 µl of dATP, dTTP, dCTP
and dGTP (10 mM each), and 1 µl SuperScript II reverse
transcriptase (200 U; Invitrogen) and incubated for 60 min at
42 °C. Reaction was inactivated by heating at 70 °C for 15 min.
PCR reactions were performed, recorded, and analyzed
using the Corbett Research system (Corbett Life Sciences,
Sydney, Australia). The conditions for PCR were as follows: 50
°C for 2 min, 95 °C for 2 min, then 30 cycles of 95 °C for 15 s,
60 °C for 1 min, and 72 °C for 15 s. The specificity of the
SYBR® green assay was confirmed by melting-point analysis.
Expression data were calculated from the cycle threshold (Ct)
value using the ΔCt method for quantification [20]. Gene
expression of HPRT was used for normalization. Results were
expressed as percent increases. All oligonucleotides and
reagents utilized in this protocol were purchased from
Invitrogen, Carlsbad, CA. Sequences used were: Nox 1 (sense
5’-CCATGAGTTTTCAATGTGGGACA -3’; antisense 5’-
AACCCCCACCGCAGACTT -3’), Nox 2 (sense 5’-
TCAAGACCATTGCAAGTGAACAC -3’; antisense 5’-
TCAGGGCCACACAGGAAAA-3’) and Nox 4 (sense 5’-
TGGGCGTCCTCGGTGGAAACT -3’; antisense 5’-
CAGGCGCCCAATACGGCCAA-3’). Statistical analyses were
performed using Graphpad Prism (3.02).
Western Blots
Total, cytosolic, and plasma membrane proteins were
prepared as described [21]. The membranes were incubated
with the following antibodies: monoclonal anti-rabbit p67phox
(1:1000; Chemicon), monoclonal anti-mouse Rac-1 (1:2000,
ABCAM) and monoclonal anti-β-actin (1:5000; Sigma). The
probed proteins were developed by using a chemiluminescent
kit (ECL, Amersham Biosciences, NJ, EUA). Films were
quantified by using the NIH ImageJ analysis system.
Immunohistochemistry
Mice were deeply anesthetized with ketamine hydrochloride
(100 mg/kg of body weight, i.m.) and xylazine (16 mg/kg of
body weight, i.m.) and subjected to transcardiac perfusion with
a buffered saline solution, followed by a fixative solution
NADPH Oxidase and Parkinson’s Disease
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comprised of 4% paraformaldehyde (PFA) dissolved in 0.1 M
phosphate buffer (PB, pH 7.4). The brains were collected, post-
fixed in PFA for 4 h, and transferred to a 30% sucrose solution
in PB to ensure cryoprotection, which lasted for 48h. Brain
sections (30 µm) were obtained on a sliding microtome
adapted for cryosectioning. The sections were incubated free-
floating for 12-16 h with anti-OX42 (CD11b/c, Biosciences, CA,
USA) to detect microglial cells and anti-tyrosine hydroxylase
(TH, Chemicon, Temecula, CA, USA) to detect DA neurons,
both diluted 1:1000 in 0.3% of Triton X-100, containing 0.05%
normal goat serum. Following 3 washes of 10 min each with
PB, sections were incubated for 2 h with a biotinylated
secondary antibody (donkey anti-mouse IgG, Jackson
ImmunoResearch, PA, USA, 1:200), then with the avidin-biotin
complex (1:100; ABC Elite kit, Vector Labs, Burlingame, CA,
USA). After washing, the sections were reacted with 0.05%
3,3-diaminobenzidine and 0.01% hydrogen peroxide in PB.
Intensification was conducted with 0.05% osmium tetroxide in
water. The sections were mounted on gelatinized slides,
dehydrated, cleared and coverslipped. Controls for
immunostaining included the omission of the primary antibody,
and its substitution for normal goat serum, which completely
eliminated staining. The material was analyzed on a light
microscope and digital images were collected. Semi-
quantitative image analysis was performed using ImageJ
software (National Institutes of Health/USA). OX42
immunostaining was evaluated in terms of optical density within
0.4 mm2 areas for SNpc. The mean optical density of striatum
and SNpc labeled areas was compared with the mean density
of neighboring, non-labeled areas in the same sections, to
obtain a labeling index reflecting the mean signal-to noise ratio,
as previously described [22]. The resulting indexes for the Wt
and gp91phox-/- groups were then compared and subjected to
statistical analysis using Graphpad Prism 3.02 (GraphPad
Software Inc., San Diego, CA, USA).
The numbers of TH-labeled cells in SNpc were determined
by serial section analysis of micrographs obtained from stained
brain sections using ImageJ. Measurements were taken from 5
different SNpc-containing sections through rostro-caudal axis
of the structure (Bregma coordinates: -3.08, -3.16, -3.20, -3.40
and -3.52) [19] for each animal and the results were averaged
and subjected to statistical analysis using the software
Graphpad Prism 3.02 (GraphPad Software Inc., San Diego,
CA, USA).
2.6 Apomorphine-induced rotation test
Apomorphine (Tocris Bioscience, Ellisville, MO, USA) was
injected i.p. at a dose of 0.1 mg/kg [23]. Mice were placed in an
automated rotometer (Rota-count, Columbus Instruments,
Columbus, OH, USA) and allowed to adapt to their
environment for 5 min before the rotations were recorded over
10 min. Results were expressed as number of rotations to the
side contralateral to the lesion per minute.
Minocycline treatment
To evaluate the impact of microglial cells inhibition in the 6-
OHDA-induced PD, Wt and gp91phox-/- mice received an i.p.
injection of PBS or minocycline (40 mg/kg) [24], a broad-
spectrum tetracycline antibiotic that exerts multiple anti-
inflammatory effects, including microglial inhibition, 7 days
before PD induction and for the following 14 consecutive days
after the lesion. Minocycline (Sigma, St. Louis, MO) was
dissolved in sterile water and sonicated to ensure complete
solubilization.
Determination of cytokines and chemokines in the
brain tissue
Concentrations of IL-4, IL-1β, IL-2, IL-10, IFN-γ, TNF-α and
RANTES were quantified in brain tissue samples using a
mouse multiplexed bead-based immunoassay Milliplex Map
Kit, MCYTOMAG-70K-PX32 (Millipore, Billerica, MA, USA)
[25]. The concentration of TGF-β1 was quantified separately
using a TGF-β1 Single Plex with a filter plate (non-magnetic
beads) Milliplex Map Kit, TGFB-64K-01 (Millipore, Billerica, MA,
USA). Briefly, SN and striatum from lesioned (6-OHDA) and
anatomically matching tissue from the contralateral control
hemisphere (saline) were collected from treated and non-
treated Wt and gp91phox-/- minocycline mice groups. The flash-
frozen brain tissue was homogenized in a buffer containing 20
mmol/L Tris-HCl (pH 7.5), 150 mmol/L NaCl, 1 mmol/L PMSF,
0.05% Tween-20, and a cocktail of protease inhibitors (Roche).
The protein concentration was measured in each sample. Each
assay plate layout consisted of six standards in duplicate, two
blank wells and up to 78 tissue samples. At the time of the
assay, samples were thawed on ice and centrifuged at
20,000×g for 2 min at 4°C and the supernatant used for the
analysis.
Cytokine and chemokine concentrations were determined
using antibodies for each analyte covalently immobilized to a
set of microspheres according to protocol developed and
validated at LINCO Research, Inc [26]. The analytes on the
surface of microspheres were then detected by a cocktail of
biotinylated antibodies. Following binding of streptavidin–
phycoerythrin conjugate, the reporter fluorescent signal was
measured with a Luminex100 reader (Luminex Corp., Austin,
TX 78727, USA). Data were calculated using a calibration
curve obtained in each experiment using the respective
recombinant proteins diluted in a lysis buffer for tissue
samples. Concentration of cytokines were calculated using
StatLIA® software (Brendan Scientific Corp., Calrsbad, CA
92008, USA) with a five-parameter logistic curve-fitting method,
and normalized to the amount of protein in each sample. The
concentration of IL-4 was below detectable levels.
Electrophoretic mobility shift assay (EMSA) to NF-κB
consensus oligonucleotide
Fifteen days after PD induction, mice were decapitated, their
brains were removed and the striatum and SN samples were
immediately collected. The samples were frozen in liquid
nitrogen and stored at -70°C until use. Each sample was
homogenized using a Dounce homogenizer in cold PBS
supplemented with 0.5 mM DTT, 0.5mM PMSF, 2 lg/ml
leupeptin, 2 lg/ml antipain, and 3 mM sodium ortovanadate and
centrifuged at 48C for 30 sec at 12,000g. Pellets were
resuspended in lysis buffer (10 mM HEPES pH 7.9, 1.5 mM
MgCl2, 10 mM KCl, 0.1 mM EDTA, 0.5 mM PMSF, 2 µg/mL
NADPH Oxidase and Parkinson’s Disease
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leupeptin, 2 µg/mL antipain, 3 mM sodium ortovanadate, 30
mM sodium fluoride, 20 mM sodium pyrophosphate) and
incubated on ice for 10 min. After the addition of NP-40 (0.5%),
samples were mixed and centrifuged for 30 s at 13,000 g.
Nuclei were resuspended in extraction buffer (20 mM HEPES,
pH 7.9, 25% glycerol, 1.5 mM MgCl2, 300 mM NaCl, 0.25 mM
EDTA, 0.5 mM PMSF, 2 µg/mL leupeptin, 2 µg/mL antipain),
incubated for 20 min on ice and centrifuged for 20 min at
13,000 g at 4°C. The remaining supernatants containing
nuclear proteins were stored at -80°C. Protein concentration
was determined using the BioRad protein reagent. EMSA to
NF-κB was performed using a gel shift assay kit from Promega
[27-29]. NF-κB double-stranded consensus oligonucleotide (5'-
AGTTGAGGGGACTTTCCCAGGC- 3') was end-labeled with
γ-32P-ATP using T4 polynucleotide kinase. Unincorporated
nucleotides were removed by running the reaction mixture
through a Sephadex G-25 spin column (Amersham-Pharmacia,
Uppsala, Sweden). Purified 32P-labeled probe (30,000 cpm)
was incubated in 20 µL with 5 µg nuclear extracts in a binding
reaction mixture containing 50 mM NaCl, 0.2 mM EDTA, 0.5
mM DTT, 4% glycerol, 10 mM Tris-HCl (pH 7.5) and 0.05 µg
poly (dI-dC) for 30 min at room temperature. DNA-protein
complexes were separated by electrophoresis through a 6%
non-denaturing acrylamide:bis-acrylamide gel in 0.5×Tris-
borate/EDTA (TBE) for 2h at 150V. Gels were vacuum-dried
and analyzed by autoradiography. Autoradiograph
quantification was performed with ImageJ (National Institutes of
Health/USA). Previous studies of our laboratory ran
competition experiments in brain control samples by using NF-
κB and TFIID (5´-GCAGAGCATATAAGGTGAGGTAGGA-3`)
unlabeled double-stranded consensus oligonucleotide in five-
to 20- fold molar excess over the amount of 32P- NF-κB probe
in order to detect specific (NF-κB) and non-specific DNA-
protein interactions (NS), respectively. To the specificity of the
assay, unlabeled oligonucleotides were added to the reaction
mixture 20 min before the radioactive probe [30,31].
Data analysis
Data were expressed as means ± standard error of the mean
(SEM) and were analyzed using two-way analysis of variance
(ANOVA), followed by pairwise comparisons (Tukey’s HSD
test). For individual comparisons, statistical analysis was
performed using unpaired Student’s t-test. In all cases, p ≤ 0.05
was considered to be statistically significant.
Results
NADPH oxidase activation in the 6-OHDA-induced PD
mice model
In order to test whether Nox isoform gene expression can be
induced by 6-OHDA, the mRNAs encoding each Nox isoforms
were evaluated by RT-PCR in striatum and SN after the lesion.
Nox1, Nox2 and Nox4 isoforms were detected in both
structures analyzed. Nox1 and Nox2 gene expression were
found to be increased in striatum (Figure 1 A-C), whereas
enhanced Nox2 gene expression was observed into SN (Figure
1F-H). Classically, activation of Nox2 requires the translocation
of its cytosolic subunits to plasma membrane. In 6-OHDA
injected Wt mice, Western blotting assays revealed no
alterations of p67phox membrane and cytosolic protein content in
either striatum or SN (Figure 1D and 1I). However, our Western
blotting assays clearly showed increased Rac-1 (a small GTP
binding protein required for the assembly of the Nox complex)
total protein content in both structures analyzed (Figure 1E and
1J).
The NADPH oxidase complex is involved in 6-OHDA-
mediated dopaminergic degeneration
Apomorphine-induced rotation tests were performed at day
14th post-lesion. Administration of apomorphine was found to
stimulate contralateral rotational behavior in Wt mice (p<0.001),
when compared to the Sham group. Gp91phox-/- 6-OHDA-
lesioned mice exhibited a significant reduction in the
apomorphine-induced rotational response (80% vs Wt 6-
OHDA-lesioned mice, p<0.001) (Figure 2A). TH-
immunolabeling indicated that unilateral striatal 6-OHDA
injections in wt mice reduced the number of DA neurons in the
SN, in comparison to the saline group. In contrast, in gp91phox-/-
6-OHDA-lesioned mice the DA degeneration was negligible
(Figure 2B), further supporting our hypothesis that Nox2 play a
role in the degeneration of DA neurons in PD.
Minocycline treatment alters the rotational behavior
and TH immunostaining in gp91phox-/--lesioned mice
By using standard immunostaining procedures, we
compared OX42 immunoreactivity in the SN of Wt and
gp91phox-/- mice in order to investigate whether the deletion of
gp91phox subunit would affect microglial cells in normal
conditions. The intensity of OX42 immunoreactivity and number
of OX42- positive cells were higher in the gp91phox-/- mice
(Figure 3A and B), suggesting that deletion of gp91phox subunit
elevates the population of microglial cells within the SN. This
observation led us to treat Wt and gp91phox-/- mice with the
microglia inhibitor minocycline to determine whether microglial
cells play detrimental or beneficial roles in gp91phox-/- mice after
PD induction. After the treatment, apomorphine-induced
rotation tests were performed to characterize the impact of
lesion induced by 6-OHDA and the minocycline effects. As
expected, the treatment with minocycline was able to
significantly decrease the number of contralateral rotations per
minute in Wt-6-OHDA-lesioned mice (40%, p<0.05). However,
the quantification of rotational behavior in gp91phox-/- lesioned
mice showed increased susceptibility of gp91phox-/- lesioned
mice treated with minocycline to develop apomorphine-induced
rotational behavior (p<0.01 - gp91phox-/- 6-OHDA lesioned vs
gp91phox-/- 6-OHDA lesioned treated with minocycline). Wt 6-
OHDA lesioned mice and gp91phox-/- lesioned mice treated with
minocycline showed similar rotation scores over repeated tests,
suggesting that microglial cells and Nox2 are involved in the
signaling pathways underlying the inflammatory response
(Figure 3C). Corroborating with these data, we also observed
that minocycline treatment reduced the degeneration of TH-
positive neurons induced by 6-OHDA in Wt mice. Nevertheless,
the same treatment was able to significantly decrease the
number of TH-positive neurons in gp91phox-/- 6-OHDA-lesioned
NADPH Oxidase and Parkinson’s Disease
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Figure 1.  Six-OHDA leads to Nox activation.  Effect of 6-OHDA on mRNAs of Nox1 (A), Nox2 (B) and Nox4 (C) isoforms in the
striatum. HPRT was used as an internal control; n=6. The statistical significance is expressed as: * P < 0.05. In D and I,
representative Western blots illustrating p67phox protein content in cytosolic and membrane fractions obtained from striatum and SN
respectively, after 6-OHDA-induced PD. Six-OHDA did not induce significant p67phox translocation from the cytosol to the plasma
membrane in none of the analyzed samples; n=4 tested samples. In E and J, effect of 6-OHDA on striatal and SN Rac-1 total
protein levels. The graphs represent the mean ratio of Rac-1 densitometric data in relation to β-actin of 5 tested samples.
Significance compared to Wt saline at **p <0.01. In F, effect of 6-OHDA on mRNAs of Nox1 (F), Nox2 (G) and Nox4 (H) isoforms in
the SN. HPRT was used as an internal control; n=6. The statistical significance is expressed as: * P < 0.05.
doi: 10.1371/journal.pone.0075532.g001
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Figure 2.  NADPH oxidase is involved in the 6-OHDA-mediated degeneration of DA neurons in SN.  A, apomorphine-induced
contralateral rotations evaluated at 14 days post-PD induction in Sham, Wt 6-OHDA-lesioned mice and gp91phox-/- 6-OHDA lesioned
mice groups; n=12. Values are expressed as percent of induced rotations/min in relation to the Sham group. Representative digital
images demonstrating TH-immunoreactive cell bodies in the SN of Wt saline, Wt 6-OHDA and gp91phox-/- 6-OHDA-lesioned mice
groups (B). Images are representative of at least six independent experiments. The statistical significance is expressed as: ***
P<0.001 versus Wt Sham group and *** p<0.001 gp91phox-/- 6-OHDA versus Wt 6-OHDA.
doi: 10.1371/journal.pone.0075532.g002
NADPH Oxidase and Parkinson’s Disease
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mice (Figure 3D and E), suggesting an enhancement of
neurodegeneration.
Minocycline treatment increases TNF-α release in the
substantia nigra of gp91phox-/--lesioned mice
The next series of experiments investigated the mechanism
by which the minocycline treatment increases the susceptibility
of gp91phox-/- 6-OHDA lesioned mice to develop PD. We
analyzed the concentration of multiple cytokines and one
chemokine in SN and striatum samples from control Wt and
gp91phox-/- mice and in 6-OHDA-lesioned mice treated with
minocycline or PBS. All the molecules measured have been
previously implicated in the pathogenesis of PD and included
proinflammatory cytokines (IL-1β, TNF-α, IFN-γ, IL-2), anti-
inflammatory cytokines (IL-10 and TGF-β1) and the chemokine
RANTES.
In striatum, 6-OHDA was able to significantly increase the
production of IFN-γ and TNF-α, which was not observed in
gp91phox-/- mice. Striatal concentration of IL-10, RANTES, IL-1β,
IL-2 and TGF-β1 remained the same after the lesion in both Wt
and gp91phox-/- mice. The basal concentration of IL-1β was
found significantly diminished in gp91phox-/- mice, when
compared to Wt mice. Minocycline treatment significantly
decreased the production of IFN-γ and TNF-α stimulated by 6-
OHDA. A trend towards a decreased production of all the
cytokines analyzed was observed after the minocycline
treatment, although, the treatment was only able to significantly
decrease the basal production of IL-10, RANTES and IL-2 in
gp91phox-/- mice and of IL-1β in Wt mice (Figure 4).
In the SN, 6-OHDA did not stimulate the production of IL-10,
RANTES, IL-1β, IL-2, TGF-β1 and IFN-γ. Unlike what was
found in striatum samples, minocycline did not change the
basal production of any of the molecules tested. The
production of TNF-α was found to be significantly increased
after 6-OHDA injection in Wt but not in gp91phox-/- mice.
However, the treatment with minocycline increased TNF-α
production in gp91phox-/- 6-OHDA injected mice, further
supporting our hypothesis that Nox-2 is modulating
inflammatory-mediated microglial responses (Figure 5).
Minocycline treatment potentiates NF-κB activation in
gp91phox-/- lesioned mice
Since NF-κB activation induces the production and release of
TNF-α, we investigate whether inhibition of microglial cells in
gp91phox-/- lesioned mice could modulate NF-κB activation. As
evaluated by EMSA, 6-OHDA did not change basal NF-κB
activity in the striatum of Wt mice (Figure 6A and B). However,
6-OHDA significantly increased NF-κB/DNA binding activity in
SN nuclear extracts, which was clearly attenuated by the
minocycline treatment. In gp91phox-/- lesioned mice, 6-OHDA did
not change basal NF-κB binding activity in either brain region,
although a trend towards an increase in SN samples has been
observed. However, minocycline treatment significantly
potentiates 6-OHDA-induced NF-κB activation in the SN of
gp91phox-/- lesioned mice (Figure 6C and D), suggesting that NF-
κB activation may be related to the increased release of TNF-α.
Discussion
The present study investigated the impact of Nox-2 in the
modulation of inflammatory-mediated microglial responses in
the 6-OHDA- induced PD. Our major findings demonstrate that
(1) The Nox2 isoform is involved in 6-OHDA-mediated DA
degeneration in SN; (2) inhibition of microglial cells by the
treatment with minocycline increases the susceptibility of
gp91phox-/- 6-OHDA lesioned mice to develop PD, as evaluated
by apomorphine-induced rotational behavior and TH
immunolabeling; (3) minocycline treatment leads to NF-κB
activation and TNF-α release into the SNpc of gp91phox-/- 6-
OHDA lesioned mice.
Minocycline, a tetracycline derivative, is a versatile drug with
a broad spectrum of action including multiple anti-inflammatory
effects, besides its anti-microbial properties. In the central
nervous system, it has been demonstrated that minocycline
inhibits apoptosis, proteolysis and the activation and
proliferation of microglial cells, triggered by several different
stimuli [32]. However, the molecular mechanisms underlying its
anti-inflammatory actions and its influence on cytokine release
are not fully understood [33]. Minocycline has been reported to
reduce dopaminergic degeneration, due to an attenuation of
microglial cell activation following unilateral 6-OHDA injection
into striatum of mice [34]. Here we investigated minocycline
ability (through microglial cell inhibition) to change the
susceptibility of gp91phox-/- 6-OHDA lesioned mice to develop
PD.
Overactivation of Noxes leads to excessive ROS production,
which disrupts redox signaling and results in oxidative stress
[35]. Independently of the ROS source, oxidative stress is
increasingly recognized as one of the most relevant
contributors to neurodegeneration [36,37].
Although the exact etiology of PD still remains largely
unknown, some studies have implicated increased ROS
production through Noxes in the pathophysiology of this
disease [38-40]. Current research also suggests that DA
neurons are inherently more vulnerable to oxidative stress,
when compared to other cell types [41]. Consistent with
previous reports, we observed that 6-OHDA induces increased
gene expression of Nox1 and Nox2 isoforms [14,15],
suggesting that Nox activation is a relevant component of the
6-OHDA-induced DA degeneration. Corroborating with this
view, a strong argument for a role of Nox2 activation in
neuronal death is the fact that gp91phox-/- exhibited significantly
reduced apomorphine-induced rotational behavior and also a
negligible degeneration of DA neurons after 6-OHDA-
injections.
Over the last decades the question of whether microglial
cells play detrimental or beneficial roles in neurodegenerative
conditions has been widely debated [42]. Similar to peripheral
macrophages, microglial cells are functionally polarized into
different activation phenotypes during neuroinflammation. It
has been recently demonstrated that Nox plays a critical role in
the modulation of the microglial phenotype. In fact,
hippocampal levels of IL-4, an anti-inflammatory cytokine, and
the expression of IL-4 receptor α mRNA were significantly
increased 24 h after intracerebroventricular injection of LPS in
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Figure 3.  Minocycline treatment alters the rotational behavior and the SN TH-immunostaining of 6-OHDA-lesioned
mice.  Representative digital images of OX42 immunoreactivity in the SN of Wt and gp91phox-/- control mice (A). The graph
represents OX42 optical density analysis; n=6 (B). The statistical significance is expressed as: * P<0.05. C, apomorphine-induced
rotational behavior evaluated after the minocycline treatment in Sham, Wt 6-OHDA-lesioned mice, Wt 6-OHDA-lesioned mice
treated with minocycline, gp91phox-/- 6-OHDA lesioned mice and gp91phox-/- 6-OHDA lesioned mice treated with minocycline groups;
n=8-10. Values are expressed as the percent of induced rotations/min in relation to the Sham group. The statistical significance is
expressed as: *** P<0.001 versus Sham group, * P<0.05 versus Wt 6-OHDA-lesioned group and *** P<0.001 versus gp91phox-/- 6-
OHDA lesioned group. D, representative digital images of TH immunoreactivity in Wt saline, Wt 6-OHDA-lesioned mice, Wt 6-
OHDA-lesioned mice minocycline, gp91phox-/- saline, gp91phox-/- 6-OHDA-lesioned mice and gp91phox-/- 6-OHDA lesioned mice
minocycline groups. E the graph depicting cell counts of TH immunostaining in the SN. The statistical significance is expressed as:
*** P<0.001 versus Wt saline group and ** P<0.01 versus gp91phox-/- saline group (n=6-8).
doi: 10.1371/journal.pone.0075532.g003
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p47phox-/- mice when compared to wt mice, indicating that
deletion of p47phox subunit alters the IL-4-dependent signaling
pathway and attenuates the inflammatory response [14].
Despite the fact that the deletion and the pharmacological
inhibition of the Nox complex promotes an anti-inflammatory
microglial activation after LPS injection, we present here strong
evidence that Nox2 plays an important role in modulating the
inflammatory response induced by 6-OHDA through a TNF-
α/NF-κB mediated signaling pathway, a likely mechanism
whereby gp91phox-/- 6-OHDA lesioned mice may be more
susceptible to develop PD after microglial cell inhibition. The
cooperative relationship between TNF-α production, a classic
Figure 4.  Effect of minocycline treatment on striatal cytokine concentration in Wt and gp91phox-/- 6-OHDA-lesioned
mice.  Striatal concentration of pro-inflammatory (IL-1β, TNF-α, IFN-γ, IL-2) and anti-inflammatory cytokines (IL-10 and TGF-β1)
and the chemokine RANTES following 6-OHDA-induced PD in Wt and gp91phox-/- treated with minocycline or PBS. All concentrations
were expressed in pg/ml. The statistical significance is expressed as: * P<0.05; ** P<0.01 and *** P<0.001; n=6 for each
experimental group tested.
doi: 10.1371/journal.pone.0075532.g004
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inflammatory cytokine, and NF-κB activation has been
previously demonstrated as an important molecular event
occurring in the 6-OHDA-induced neurodegeneration [43,44].
TNF-α release has been identified as a critical mechanism
involved in DA neuroinflammation and in neuron damage.
Continuous production of this cytokine induced by an
adenoviral vector leads to chronic microglia and macrophage
activation in the SN, progressive neurodegeneration, and
delayed motor symptoms [45]. Among all the cytokines
evaluated in the present study, we observed that microglial cell
Figure 5.  Effect of minocycline treatment on substantia nigra cytokine concentration in Wt and gp91phox-/- 6-OHDA-lesioned
mice.  Concentration of pro-inflammatory (IL-1β, TNF-α, IFN-γ, IL-2) and anti-inflammatory cytokines (IL-10 and TGF-β1) and the
chemokine RANTES in the substantia nigra following 6-OHDA-induced PD in Wt and gp91phox-/- treated with minocycline or PBS. All
concentrations were expressed in pg/ml. The statistical significance is expressed as: * P<0.05; ** P<0.01 and *** P<0.001; n=6 for
each experimental group tested.
doi: 10.1371/journal.pone.0075532.g005
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Figure 6.  Minocycline treatment potentiates NF-κB activation in gp91phox-/- 6-OHDA lesioned mice.  In A, representative panel
of NF-κB activation in striatal nuclear extracts. In B, densitometric analysis of NF-κB bands obtained from nuclear extracts of
striatum. In C, representative panel of NF-κB activation in SN nuclear extracts. In D, densitometric analysis of the NF-κB bands
obtained from nuclear extracts of SN. The statistical significance is expressed as: * P<0.05; ** P<0.01 and *** P<0.001; n=4.
Competition studies were performed using brain extract (15 µg) in the absence or presence of unlabeled specific (NF-κB consensus
sequence, 5-, 10- and 20- fold molar excess) or non-specific oligonucleotide (TFIID consensus sequence, 20- fold molar excess), as
indicated. The position of specific NF-κB/DNA binding complexes is indicated (NF-κB). NS represents no specific binding (NS). The
localization of the probe is also indicated. Results are representative of three experiments.
doi: 10.1371/journal.pone.0075532.g006
NADPH Oxidase and Parkinson’s Disease
PLOS ONE | www.plosone.org 11 September 2013 | Volume 8 | Issue 9 | e75532
inhibition increased TNF-α production into the SN of
gp91phox-/--6-OHDA lesioned mice. It is noteworthy that
astrocytes are able to release TNF-α [46], which could be one
possible explanation for the increased TNF-α concentration in
the SN of gp91phox-/--6-OHDA lesioned mice after microglial cell
inhibition observed in the present study. Increased LPS-
induced TNF-α release from astrocyte cultures has been
demonstrated [47], and increased astrocytic immunoreactivity
for TNF-α was observed in the SN of parkinsonian patients
[48]. In addition, in parkinsonian monkeys TNF-α
immunoreactivity was observed very close to GFAP
immunoreactivity in activated astrocytes, which suggests that
TNF-α synthesis and/or release may be intimately linked with
the astrocyte cytoskeleton [49].
We also observed in gp91phox-/- 6-OHDA lesioned mice that
minocycline treatment potentiated the activation of NF-κB,
which can induce TNF-α production [50], suggesting the
participation of that transcription factor in the process.
However, considering that TNF-α release may also trigger a
signaling cascade that can converge on the activation of the
transcription factor NF-κB [51], whether NF-κB activation
precedes TNF-α production is an issue that remains to be
determined.
Since inhibition of microglial cells by minocycline treatment
increased the susceptibility of gp91phox-/- 6-OHDA lesioned mice
to develop PD and exacerbated the pro-inflammatory response
induced by the neurotoxin, our results further strengthen the
hypothesis that Nox2 adds an essential level of regulation to
signaling pathways underlying the inflammatory response after
PD induction. The Nox complex may play a role not only in the
signaling events leading to microglia activation, but may also
act as an important modulator of signal transduction in other
cell types. Our results are also likely to provide further insights
in the direction of a better understanding of the mechanisms of
Nox-dependent oxidative stress involvement in
pathophysiological conditions.
Conclusions
We demonstrated here that inhibition of microglial cells in
gp91phox-/- 6-OHDA lesioned mice triggers DA degeneration and
exacerbated the pro-inflammatory response induced by the
neurotoxin through a TNF-α/NF-κB mediated signaling
pathway. Our results suggest that Nox2 adds an essential level
of regulation to signaling pathways underlying the inflammatory
response after PD induction, and indicated that both Nox2 and
microglial cells could represent therapeutics targets in PD.
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